AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2024

Aug 7, 2024

30016_dirs_2024-08-07_e6d47f14-a637-44ee-be59-c18e832048b6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-08-05

Reporting Person: MAZELSKY JONATHAN JAY (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-05	Common Stock	M	384	—	Acquired	81902.5926	Direct
2024-08-05	Common Stock	F	170	$455.08	Disposed	81732.5926	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-05	Restricted Stock Unit	$	M	384	Disposed		Common Stock (384)	Direct

Footnotes

F1: Includes a total of 22 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024 and June 28, 2024.

F2: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning August 5, 2020.

F3: Not applicable.